多种躯体主诉的临床试验
总计10976个结果
-
A.T. Still University of Health Sciences完全的
-
The Touro College and University System招聘中
-
New York Institute of Technology完全的Segmental and Somatic Dysfunction of Other Regions (M99.09)美国
-
Centre Hospitalier Universitaire Dijon完全的
-
Central Hospital, Nancy, France完全的
-
First Affiliated Hospital Xi'an Jiaotong UniversitySecond Affiliated Hospital of Wenzhou Medical University完全的
-
Rowan UniversityAmerican Osteopathic Association完全的
-
University of Lugano完全的Group 1 (Control): Access to a Static Version of the Website Containing Only Static Features (i.e. Library, First Aid, and FAQ) | Group2 (Intervention) Access to an Interactive Version of the Website Containing Both Static and Interactive Features瑞士
-
Rabin Medical Center完全的
-
Biogen撤销
-
Novartis Pharmaceuticals完全的
-
M.D. Anderson Cancer Center完全的
-
The Second Hospital of TangshanChinese PLA General Hospital完全的
-
Mayo Clinic邀请报名帕金森综合症 | 语义痴呆 | 额颞痴呆的行为变异 | 生物多样性公约 | 言语失用症 | MSA-- 多系统萎缩 | FTD | PPA | 掌上电脑 | 主成分分析 | LPA | 语义性失语美国
-
Sihuan Pharmaceutical Holdings Group Ltd.未知
-
Merck KGaA, Darmstadt, GermanyMerck Quimica Argentina S.A.I.C完全的
-
Biogen完全的Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)复发缓解型多发性硬化症比利时, 卢森堡, 英国
-
Harpoon Therapeutics主动,不招人多发性骨髓瘤 | 多发性骨髓瘤复发 | 缓解失败的多发性骨髓瘤 | 骨多发性骨髓瘤美国, 西班牙, 法国
-
UMC Utrecht终止
-
Tel-Aviv Sourasky Medical Center未知评估 IT MTX 治疗对进展性 MS 患者病程的影响
-
University of California, Los Angeles未知